Page 143 - Orange Book Cumulative Supplement 10 October 2012
P. 143
A - 6
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
CICLOPIROX - LOPROX
N021159 001 8227490 Sep 16, 2017 U-1256
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE - PREPOPIK
N202535 001 NP Jul 16, 2015
CLEVIDIPINE BUTYRATE - CLEVIPREX
N022156 001 5856346 Jan 05, 2021 DS DP U-893
CLEVIDIPINE BUTYRATE - CLEVIPREX
N022156 002 5856346 Jan 05, 2021 DS DP U-893
CLOBETASOL PROPIONATE - CLOBETASOL PROPIONATE
A078223 001 PC Jun 30, 2012
CLOBETASOL PROPIONATE - CLOBETASOL PROPIONATE
A078854 001 PC Jun 30, 2012
CLOPIDOGREL BISULFATE - CLOPIDOGREL BISULFATE
A077665 002 PC Nov 13, 2012
CLOPIDOGREL BISULFATE - CLOPIDOGREL BISULFATE
A091023 001 PC Nov 13, 2012
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - STRIBILD
N203100 001 5814639 Sep 29, 2015 DS DP
5914331 Jul 02, 2017 DS
5922695 Jul 25, 2017 DS U-257
5935946 Jul 25, 2017 DS DP U-257
5977089 Jul 25, 2017 DS DP U-257
6043230 Jul 25, 2017 U-257
6642245 Nov 04, 2020 U-257
6703396 Mar 09, 2021 DS DP
7176220 Nov 20, 2023 DS DP U-257
7635704 Jan 12, 2026 DS DP U-257
8148374 Sep 03, 2029 DS DP U-1279
COLCHICINE - COLCRYS
N022352 001 7964648 Oct 06, 2028 U-1161
8097655 Oct 06, 2028 U-1020
CRIZOTINIB - XALKORI
N202570 001 8217057 Nov 06, 2029 DS DP
CRIZOTINIB - XALKORI
N202570 002 8217057 Nov 06, 2029 DS DP
CYSTEAMINE HYDROCHLORIDE - CYSTARAN
N200740 001 >A> NP Oct 02, 2015
>A> ODE Oct 02, 2019
DAPTOMYCIN - CUBICIN
N021572 002 8129342 Nov 28, 2020 DS DP